Monoclonal antibodies reacting with the MUC2 mucin core protein
1993
Monoclonal Antibodies Against MUC2 Mucin
publication
Evidence: moderate
Author Information
Author(s): P.L. Devine, M.A. McGuckin, G.W. Birrell, R.H. Whitehead, G.P. Sachdev, P. Shield, B.G. Ward
Primary Institution: Department of Obstetrics and Gynaecology, University of Queensland
Hypothesis
The study aimed to produce monoclonal antibodies that react with the MUC2 core protein.
Conclusion
The produced monoclonal antibodies showed strong reactivity with various tumors and may be useful for diagnosis and therapy.
Supporting Evidence
- Two monoclonal antibodies, 3A2 and 4F1, were produced and showed specific reactivity with MUC2.
- Immunohistochemical analysis revealed strong reactivity with lung, gastric, and colon tumors.
- The antibodies reacted with immature mucin in normal tissues but showed strong staining in tumors.
- Both antibodies were effective in identifying MUC2 in various cancer types.
Takeaway
Scientists made special antibodies that can find a protein in certain cancers, which might help doctors diagnose and treat these cancers better.
Methodology
The study involved immunizing female BALB/c mice with mucin from colon cancer cells and synthetic peptides to produce monoclonal antibodies.
Want to read the original?
Access the complete publication on the publisher's website